Elegen
PrivateLast Round
Series B
May 14, 2024
Est. Valuation
$100M
Total Funding Raised
$36.21M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Elegen is a biotechnology company specializing in microfluidics technology that aims to revolutionize synthetic biology through genome engineering and rapid DNA synthesizer development to enhance biomedical progress and DNA sequence testing in healthcare.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Pharma Supply Chain
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Elegen Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Elegen Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 14, 2024 | ||||
| Grant | Sep 23, 2020 |
Elegen Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Series B |
| Digitalis Ventures | Series B |
| Triatomic Capital | Series B |
| Alix Ventures | Series B |
| ACVC Partners | Series B |
| 8VC | Series B |
| AME Cloud Ventures | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2026
Dr. Marc Unger, inventor of the Nanoflex valve, joins as an advisor.
- Jul 15, 2025
Joint pilot program with Nutcracker Therapeutics for RNA-based therapeutics.
Elegen Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Elegen's valuation, stock price, and market status.